Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus)
|
|
|
- Bernard Smith
- 10 years ago
- Views:
Transcription
1 A Datamonitor report Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) Published: Oct 07 Product Code: DMTC2133 Providing you with: Identifies which technology vendors pharmaceutical companies should 'shortlist' when considering the purchase of a CRM solution Provides a comparative technology assessment of the CRM solutions offered by leading vendors in the pharmaceutical market, globally Identifies which CRM solution providers have the most impact on the pharmaceutical market Use this report to... Understand the topography of the competitive landscape for CRM in the pharmaceutical industry Explores how end users perceive CRM vendors across eight categories such as product quality and service capabilities
2 Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) DMTC2133 Introduction This report provides a comparative analysis of the leading CRM vendors in the pharmaceutical industry in order to help companies select a CRM solution based on its technology strength, reputation amongst end users and ability to influence the market. Key findings and highlights By combining robust CRM technology with extensive market impact in the pharmaceutical sector, Oracle is positioned as the leader for CRM solutions in the life sciences; With its recent acquisition of Dendrite, Cegedim has increased its market impact and has positioned itself as an important leader in the pharmaceutical CRM market; By offering new technology platforms StayinFront and Salesforce.com have become important players in the pharmaceutical CRM landscape; and While still a newcomer, Verticals ondemand, boasts domain expertise and a competitive end-user interface. Reasons to buy Understand the topography of the competitive landscape for CRM in the pharmaceutical industry Identify the strengths and weaknesses of leading CRM vendors and their solutions Obtain insight into how IT managers in Pharma perceive key vendors in the market for CRM Contact us... From Europe: tel: fax: [email protected] From the US: tel: fax: [email protected] From Asia Pacific: tel: fax: [email protected]
3 Sample pages from the report Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Industry Figure 1: The CRM in Pharma Decision Matrix* User sentiment (scale 1-10) Salesforce.com Verticals ondemand Cegedim Dendrite Oracle Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Industry 5.0 StayinFront recognized solution amongst surveyed respondents and it is also the solution that receives the highest scores across all end-user categories. Similarly, end users recognize and assign equally high scores to Dendrite products, assigning them one of the highest scores for the most specialized products in the pharmaceutical market. This finding seems to indicate that as long 8.0as a product meets specific 9.0 industry needs, it is irrelevant whether or not the solution was originally developed Technology assessment for the pharmaceutical industry exclusively or whether the solution evolved from a horizontal product. (scale 1-10) Explore Consider Shortlist Bubble size represents Market Impact Figure 3: Market leaders analysis: User sentiment Impact = 0 Impact = 10 Source: Datamonitor * Definitions of Market Impact, Technology, Sentiment and the Decision Matrix ratings can be found in the appendix. D A T A M O N I T O R Product quality 10 Client engagement 9 8 Decision Matrix: Customer Selecting support a CRM Vendor in the Pharmaceutical Industry Financial stability Despite the fact that Cegedim Dendrite and Oracle have considerable presence in the pharmaceutical CRM market, at the same time some of the smallest vendors offering new technology platforms are also the most successful or the fastest growing. As a leading on-demand CRM specialist, Salesforce.com is one of the market leaders in the new customer category. Similarly, Service Verticals capabilities ondemand is likely to play an important role in the competitive landscape, offering an innovative product that seems to meet the industry s need like a glove. Therefore, such on-demand vendors are expanding rapidly both because they are less mature and because their business model is based on rapid mass adoption. Decision Matrix: Selecting a CRM vendor in the pharmaceutical industry (Competitor Focus) DMTC2133/ Published 10/2007 Figure 4: Market leaders analysis: Market impact Service levels Datamonitor. This brief is a licensed product and is not to be photocopied Page 6 Vertical specialization Portfolio depth CRM installed base Cegedim Dendrite Oracle Salesforce.com StayinFront Verticals ondemand Company size Pharma Revenue 4 Source: Datamonitor D A T A M O N I T O R 2 Solution addressable installed base 0 Revenue growth As the pharmaceutical CRM Decision Matrix includes vendors with markedly different delivery models, it is important to note the perception of end users about on-demand vendors, such as Salesforce.com, compared to traditional vendors. As shown in Figure 3, Salesforce.com is one of the top three vendors in this category, receiving top scores for its customer Recognition New Customers Decision Matrix: Selecting a CRM vendor in the pharmaceutical industry (Competitor Focus) DMTC2133/ Published 10/2007 Geographic reach Datamonitor. This brief is a licensed product and is not to be photocopied Page 11 Cegedim Dendrite Oracle Salesforce.com StayinFront Verticals ondemand Source: Datamonitor D A T A M O N I T O R Decision Matrix: Selecting a CRM vendor in the pharmaceutical industry (Competitor Focus) DMTC2133/ Published 10/2007 Datamonitor. This brief is a licensed product and is not to be photocopied Page 13...Probably the most promising drugs are those with different mechanisms of action, like HCV protease inhibitors, and the other small molecules like polymerase inhibitors... EU key opinion leader, Stakeholder Opinions Hepatitis C Small-molecule antivirals pave the way for triple therapy
4 Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) DMTC2133 Table of contents DATAMONITOR VIEW CATALYST SUMMARY METHODOLOGY MARKET DEVELOPMENTS The competitive landscape for CRM in the life sciences is entering a new phase The CRM in Pharmaceuticals Decision Matrix - Oracle is the top leader by striking the right balance between industry specificity and functionality - Cegedim Dendrite is a leading vendor with strong industry expertise and an expanded installed base - With a new delivery model and strong end-user sentiment Salesforce.com is building momentum - StayinFront offers robust multi-channel capabilities on an updated technology platform - Verticals ondemand's VBioPharma CRM product will change the competitive landscape MARKET LEADERS Market leaders: Technology Assessment Market leaders: User sentiment Market leaders: Market Impact APPENDIX Definitions Datamonitor Ratings Extended methodology - Technology - User sentiment - Market Impact Further reading Ask the analyst LIST OF TABLES Table 1: The CRM in Pharma Decision Matrix* LIST OF FIGURES Figure 1: The CRM in Pharma Decision Matrix* Figure 2: Market leaders analysis: Technology Figure 3: Market leaders analysis: User sentiment Figure 4: Market leaders analysis: Market impact Figure 5: The Cegedim CRM in Pharma Radar: Teams Figure 6: The Dendrite CRM in Pharma Radar: Mobile Intelligence Figure 7: The Oracle CRM in Pharma Radar: Siebel Figure 8: The Salesforce.com CRM in Pharma Radar Figure 9: The StayinFront CRM in Pharma Radar Figure 10: The Verticals ondemand CRM in Pharma Radar THE CURRENT STANDARD OF CARE THERAPY - PEG-IFN ALFA PLUS RIBAVIRIN - HAS A SUBOPTIMAL TOLERABILITY AND EFFICACY PROFILE VENDOR ANALYSIS Oracle - Siebel: CRM in Pharma Radars - Recommendation: Shortlist Cegedim Dendrite - Teams: CRM in Pharma Radars - Recommendation: Shortlist Cegedim Dendrite - Mobile Intelligence: CRM in Pharma Radars - Recommendation: Shortlist Salesforce.com: CRM in Pharma Radars - Recommendation: Consider StayinFront: CRM in Pharma Radars - Recommendation: Consider Verticals ondemand: CRM in Pharma Radars - Recommendation: Explore Contact us... From Europe: tel: fax: [email protected] From the US: tel: fax: [email protected] From Asia Pacific: tel: fax: [email protected]
5 Datamonitor: Your total information solution Datamonitor is a premium business information company helping 5,000 of the world's leading companies across the Automotive, Consumer Markets, Energy, Financial Services, Healthcare and Technology sectors. Our products and services are specifically designed to support our clients key business processes from corporate strategy to competitive intelligence. We provide an independent and trustworthy source of data, analysis and forecasts to improve these processes and ultimately, to help grow your business. Corporate Strategy & Business Planning Quality Data Make more effective strategic and business decisions Product Development & Commercialization Targeting & Influencing the Market Expert Analysis Accelerate delivery of commercial success Assess and influence your commercial and market environment HELPING TO GROW YOUR BUSINESS Market & Competitive Intelligence Future Forecasts Maintain or obtain critical competitive advantage Nothing speaks louder than our clients 3M Abbott Accenture Alcon Labs Allergan Almirall-Prodesfarma Altana Pharma AG Amersham Amgen Amrad Angelini Acraf Astellas AstraZeneca AT Kearney Baxter Bayer Healthcare AG Beaufour Ipsen Biochemie Biogen Idec Boehringer Ingelheim Boots Bristol-Myers Squibb Cantab Caremark International Chiesi Chiron Chugai CMC Co Daiichi Deutsche Morgan Grenfell Elan Eli Lilly Esteve Flamel Fournier Gehe Genzyme Gilead Gist Brocades GlaxoSmithKline IBM Immuno AG Johnson & Johnson Jouveinal LEK Lipha Lundbeck Merck KGaA Merck & Co Millennium Pharmaceuticals Nabi Biopharmaceuticals Novartis Novo Nordisk Pfizer Pharmachemie Pierre Fabre Pliva Procter & Gamble Ranbaxy Recordati Sankyo sanofi-aventis Schering AG Schering-Plough Schwarz Pharma AG Serono Shire Pharmaceuticals Solvay Pharmaceuticals Takeda TAP Pharmaceutical Teva UCB Uriach Vernalis Viatris Wyeth...89% of our clients use Datamonitor research to develop competitive intelligence... Source: Datamonitor Customer Research
6 Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) DMTC2133 Interested in this topic? Datamonitor s Public Sector Technology portfolio offers strategic research and advisory services that provide guidance for understanding the competitive landscape of the public sector and identifying opportunities in it. The contraction of private sector ICT spend and the emergence of egovernment initiatives have generated renewed interest for vendors in the public sector. Our expertise is focused on: technology to reach citizens, their uptake and the steps government is taking to meet these demands; streamlining systems and cutting costs; and technology procurement processes. Also available in this portfolio Future Spending of CRM Technologies, North America and Japan, (Databook) Forecast of CRM market size in Pharmaceuticals from Published: Jul-07 Product code: DBTC0046 Future Spending of CRM Technologies, Europe, (Databook) Forecast of CRM market size in Pharmaceuticals from Published: Jul-07 Product code: DBTC0047 Falling Margins in Pharma - increasing ROI through CRM (Market Focus) As the profit margins of pharmaceutical companies are squeezed there is a need for the industry to find greater efficiency in their sales force - and CRM can help resolve this problem. Published: Jul-07 Product code: BFTC1771 Bringing Drugs to Market The role of CRM in improving sales & marketing (Executive Presentation) This PowerPoint presentation provides a succinct review of all products from the Pharmaceutical Technology theme for Q3 2007: Bringing Drugs to Market The role of CRM in improving sales & marketing. Published: Jun-07 Product code: BFTC1774 For more information about our products visit Subscribe to Healthcare Monitor A monthly update of the latest Healthcare products, events, news and special offers from Datamonitor delivered to you by . To subscribe your contact details to [email protected] with subscribe in the subject line.
7 Place your order now... Fax back to (from Europe), (from the US) or (from Asia Pacific) I would like to order: Product title Product code Price / / $ / * * Please refer to our website for up-to-date prices Complete your details: Name Job Title Department Company Address State/Province Post Code/ZIP Country Tel Fax Sign below to confirm your order: Complete payment details: Please indicate your preferred currency option: UK Euro US$ Yen I enclose a check payable to Datamonitor Ltd for (+ p+p $30 UK / $60 rest of world) Please invoice my company for (+ p+p $30 UK / $60 rest of world) Please debit my credit/charge card Amex Visa Diners Mastercard Card No Expiry Date / Cardholder Signature Cardholder address Please supply purchase order number here if required by your accounts department: EU companies (except UK) must supply: VAT / BTW / MOMS / MWST / IVA / FPA number: Datamonitor products and services are supplied under Datamonitor s standard terms and conditions, copies of which are available on request. Payment must be received within 28 days of receipt of invoice. I do not want to receive future mailings from Datamonitor and its related companies. Occasionally, our client list is made available to other companies for carefully selected mailings. Please check here if you do not wish to receive such mailings. Datamonitor Ltd. Registered in England. Registered No Registered Office: Finchley Road, London NW3 5JJ DMTC2133WEB From Europe: tel: fax: [email protected] From the US: tel: fax: [email protected] From Asia Pacific: tel: fax: [email protected] Contact us to find out more about our products and services
Stakeholder Perspectives: Mild Cognitive Impairment and Dementia
A Datamonitor In-Depth Analysis Stakeholder Perspectives: Mild Cognitive Impairment and Dementia Aricept in Race to Pioneer Unexplored Markets Published: Aug-03 Product Code: DMHC1924 Why buy this analysis?
Commercial Insight Osteoarthritis and Rheumatoid Arthritis
A Datamonitor In-Depth Analysis Commercial Insight Osteoarthritis and Rheumatoid Arthritis New Growth In A Mature Market Published: Jul-03 Product Code: DMHC1891 Why buy this analysis? Target current and
ehealthinsight Series: Online Patient Recruitment Strategies
A Datamonitor report ehealthinsight Series: Online Patient Recruitment Strategies Published: May-08 Product Code: Providing you with: Overview of benefits and drawbacks of online Analysis of online patient
Stakeholder Insight: Insulin Use in Type 2 Diabetes
A Datamonitor Report Stakeholder Insight: Insulin Use in Type 2 Diabetes From Last Resort to Early Intervention Published: May-04 Product Code: DMHC1989 Providing you with: Analysis of Datamonitor s Diabetes
Commercial Perspectives: Multiple Sclerosis
A Datamonitor Report Commercial Perspectives: Multiple Sclerosis How to Find Opportunities in an Unremitting Market Published: Jun-04 Product Code: Providing you with: In-depth profiles of current market-leading
Stakeholder Insight: Rheumatoid Arthritis Biologics battle up the treatment algorithm
A Datamonitor report Stakeholder Insight: Rheumatoid Arthritis Biologics battle up the treatment algorithm Published: Sep-06 Product Code: Providing you with: Disease overview including epidemiology, physician
Pipeline Insight: Schizophrenia Asenapine; A future market leader?
A Datamonitor report Pipeline Insight: Schizophrenia Asenapine; A future market leader? Published: Jul-06 Product Code: DMHC2186 Providing you with: Detailed pipeline analysis for key products in development
Financial Services Outsourcing and Services Targeting Key Insurance BPO Opportunities: NA and EMEA
A Datamonitor report Financial Services Outsourcing and Services Targeting Key Insurance BPO Opportunities: NA and EMEA Targeting market growth Providing you with: Published: Sep-06 Product Code: DMTC1654
Decision Matrix: Selecting a Contact Center Analytics Vendor (Competitor Focus) Analytics and Reporting As Differentiators in a Difficult Economy
Decision Matrix: Selecting a Contact Center Analytics Vendor (Competitor Focus) Analytics and Reporting As Differentiators in a Difficult Economy Report summary An overview of the most important trends
Fleet Markets Presentation 2005
A Datamonitor report Fleet Markets Presentation 2005 Published: Sep-05 Product Code: DMAU0279 Providing you with: Sizes of the company car market and main financing methods used within the market in the
CRM and ERP Technologies in Healthcare
A Datamonitor report CRM and ERP Technologies in Healthcare France, Germany, the UK and the US Published: Dec-04 Product Code: DMTC1078 Providing you with: Details of the markets for CRM application software
Stakeholder Insight: Non-Small Cell Lung Cancer The Need for Greater Product Differentiation in an Increasingly Crowded Market
A Datamonitor report Stakeholder Insight: Non-Small Cell Lung Cancer The Need for Greater Product Differentiation in an Increasingly Crowded Market Published: Oct-06 Product Code: DMHC2223 Providing you
Outsourcing and IT Services in Financial Services Infrastructure Outsourcing (Review Report)
A Datamonitor report Outsourcing and IT Services in Financial Services Infrastructure Outsourcing (Review Report) The growth areas in financial services infrastructure outsourcing to 2008 Published: Oct-06
Outsourcing of Fleet Management in Mature Markets
A Datamonitor Brief timely Outsourcing of Fleet Management in Mature Markets Publication Date: Sep-06 Product Code: Reacting to the latest news breaking in your industry focused primary research Will the
CRM in Higher Education
A Datamonitor report Institutions of higher education use technology to strengthen relationships with constituents Published: Feb-05 Product Code: Providing you with: The results of phone-based interviews
The MPLS VPN Market in the UK: Perspectives on the Next-generation Wide Area Network
A Datamonitor Brief timely The MPLS VPN Market in the UK: Perspectives on the Next-generation Wide Area Network Reacting to the latest news breaking in your industry Publication Date: Oct-04 Product Code:
Customer Retention in the Life and Pension Market: To Have and To Hold
A Datamonitor brief timely Customer Retention in the Life and Pension Market: To Have and To Hold Publication Date: Feb-04 Product Code: Reacting to the latest news breaking in your industry focused Hundreds
UK Bridging Loans 2006
A Datamonitor Report timely UK Bridging Loans 2006 Publication Date: Nov-06 Product Code: Reacting to the latest news breaking in your industry focused primary research Bridging loans are short-term secured
Energy Brokers: Friend or foe?
A Datamonitor Brief Energy Brokers: Friend or foe? Publication Date: Apr-06 Product Code: focused Hundreds of hours of analyst time distilled into a few pages While competing directly with suppliers, Third
Pipeline Insight: Non-insulin Antidiabetics Type 2 diabetes unlikely to develop into a switch market
A Datamonitor report Pipeline Insight: Non-insulin Antidiabetics Type 2 diabetes unlikely to develop into a switch market Published: Aug-06 Product Code: Providing you with: Assessment of the patient potential
Vertical Guide to Call Centers in EMEA
A Datamonitor report Vertical Guide to Call Centers in EMEA Analyzing trends in EMEA call centers Published: Apr-04 Product Code: Providing you with: Use this report to... Determine the largest and fastest
UK General Insurance Competitor Tracker - Q2 2007 (Competitor Focus)
A Datamonitor Brief timely UK General Insurance Competitor Tracker - Q2 2007 (Competitor Focus) Reacting to the latest news breaking in your industry focused Publication Date: Jul-07 Product Code: primary
Decision Matrix Selecting an IVR Vendor in the Enterprise (Competitor Focus)
A Datamonitor report Decision Matrix Selecting an IVR Vendor in the Enterprise (Competitor Focus) Differentiating a Commoditizing Technology Published: Jan-09 Product Code: DMTC2245 Providing you with:
The Potential for Bundled Insurance Products
A Datamonitor Brief timely The Potential for Bundled Insurance Products Publication Date: Aug-04 Product Code: Reacting to the latest news breaking in your industry focused Hundreds of hours of analyst
Managed and Hosted Contact Center Services
A Datamonitor report Managed and Hosted Contact Center Services Generating New Sources of Revenue for Vendors and Service Providers Published: Dec-04 Product Code: Providing you with: Hosted contact centers,
Current Account and Offset Mortgages
A Datamonitor brief timely Current Account and Offset Mortgages Reacting to the latest news breaking in your industry focused Publication Date: Oct-03 Product Code: Hundreds of hours of analyst time distilled
Customer Retention Strategies for the European Electricity Mid Market
A Datamonitor report Customer Retention Strategies for the European Electricity Mid Market Improving ROI while maximising retention rates Why buy this report? Published: Jul-03 Product Code: DMEN0257 Mid-market
Long-term Care Insurance: Where are the Opportunities in Europe?
A Datamonitor Brief timely Long-term Care Insurance: Where are the Opportunities in Europe? Reacting to the latest news breaking in your industry focused Publication Date: Jun-04 Product Code: primary
Global Consumer Money Transfer Market
A Datamonitor brief timely Global Consumer Money Transfer Market Publication Date: May-04 Product Code: Reacting to the latest news breaking in your industry focused Hundreds of hours of analyst time distilled
B2B ecommerce implementation market, 2000-2005. Ongoing services $8,510m 30% US 20% $8,750m Software 10%
BUSINESS INSIGHTS B2B ecommerce From EDI to emarketplaces Read this report today and ensure you turn your B2B investment into profit... B2B ecommerce implementation market, 2000-2005 40% RoW $2,640m Ongoing
Call Center Outsourcing in Western Europe
A Datamonitor report Call Center Outsourcing in Western Europe Identifying opportunities in a maturing market Published: Aug-05 Product Code: Providing you with: Complete market sizing and forecasts across
The Future Role of Brandassurers in UK General Insurance
A Datamonitor Brief timely The Future Role of Brandassurers in UK General Insurance A Brand New Insurance Channel Reacting to the latest news breaking in your industry focused Publication Date: Jun-04
Contact Center Markets and Technologies Targeting Growth in Developing Markets: APAC, CEE, CALA
A Datamonitor report Contact Center Markets and Technologies Targeting Growth in Developing Markets: APAC, CEE, CALA Challenges and opportunities of the offshore markets Published: Jul-06 Product Code:
Commercial Fuel Cards in Europe: Obstacles and Opportunities
A Datamonitor Brief Commercial Fuel Cards in Europe: Obstacles and Opportunities timely Reacting to the latest news breaking in your industry focused Publication Date: May-06 Product Code: Hundreds of
Profiting from the Changing Tools Market for Speech Applications
A Datamonitor report Profiting from the Changing Tools Market for Speech Applications The times they are a-changin Published: Dec-05 Product Code: Providing you with: Description of the trends of the global
UK Motorcycle Insurance
A Datamonitor Brief timely UK Motorcycle Insurance Publication Date: Nov-04 Product Code: Reacting to the latest news breaking in your industry focused primary research This report is a consolidated source
Marketing Financial Services to the Over 50s
A Datamonitor report Marketing Financial Services to the Over 50s Published: Dec-04 Product Code: Providing you with: Use this report to Better plan your business strategies with the help of in-depth analysis
The Top 10 Oil & Gas Companies
BUSINESS INSIGHTS The Top 10 Oil & Gas Companies Growth strategies, consolidation and convergence in the leading players New Energy Management Report Distribution of global natural gas reserves North America
Targeting NRIs in Wealth Management
A Datamonitor report Targeting NRIs in Wealth Management A ready-made global wealth management customer segment Published: Apr-06 Product Code: Providing you with: Analysis on the growing trend among financial
CHEM-E4140 Selectivity 12. Pharma Business
CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25
The Role of Banks and Building Societies in UK General Insurance
A Datamonitor report The Role of Banks and Building Societies in UK General Insurance Current and Future Trends Published: Dec-04 Product Code: Providing you with: Current and future market shares of the
Pharma working capital performance highly variable
April 2014 Pharma working capital performance highly variable 41 Billion in Excess Working Capital We last completed this survey in 2012. We expected that there would be a broad improvement across the
December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES
December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES by Dennis van Rooij with Tim van Tongeren EXECUTIVE SUMMARY More than half of pharma marketers don t or can t leverage
The Global Pricing Guide to Offshore Outsourcing
A Datamonitor report The Global Pricing Guide to Offshore Outsourcing Balancing the Risks and Rewards of Offshore and Nearshore Outsourcing Published: Sep-04 Product Code: Providing you with: Information
Product Differentiation in Asia Pacific Credit Cards
A Datamonitor Brief timely Product Differentiation in Asia Pacific Credit Cards Publication Date: Sep-04 Product Code: Reacting to the latest news breaking in your industry focused primary research In
Competitor Profiles of the Top UK Commercial Insurers
A Datamonitor report Competitor Profiles of the Top UK Commercial Insurers Published: Jul-05 Product Code: Providing you with: Key statistical data on each of the players profiled including GEP, market
Branch Renewal Execution Strategies in European Retail Banking
A Datamonitor report Branch Renewal Execution Strategies in European Retail Banking Delivering Profitable Business Models for the Branch Published: Dec-04 Product Code: Providing you with: Coverage of
Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct
Outcomes of Monitoring Committee Reviews Medicines Australia Code of Conduct 1 Medicines Australia ABN 23 126 990 001 Level 1, 16 Napier Close Deakin ACT 2600 Phone: 02 6122 8500 Fax: 02 6122 8555 Web:
Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth
Brochure More information from http://www.researchandmarkets.com/reports/2640803/ Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine
Annual Press Conference 2012. Business Year 2011
Business Year 2011 Highlights of the Business Year 2011 Andreas Barner Chairman of the Board of Managing Directors Corporate Board Division Pharma Research, Development and Medicine Value through Innovation
Blockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global
Content Management in the Pharmaceutical Industry An Overview Blockbuster!!! Avatar USD 2 Billion revenues Lipitor USD 12.5 Billion in 2008 Dr Arun Gangatkar http://in.linkedin.com/in/drarungangatkar [email protected]
UK Employers Liability Insurance 2007
A Datamonitor report UK Employers Liability Insurance 2007 A comprehensive guide to the market Published: Apr-07 Product Code: Providing you with: Analyzis of the competitive issues and prevailing trends
KEEPING CLINICAL TRIALS IN AUSTRALIA
OCCASIONAL PAPER SERIES KEEPING CLINICAL TRIALS IN AUSTRALIA WHY ACTION IS NEEDED NOW OCCASIONAL PAPER SERIES > Medicines Australia is producing Occasional Papers to promote a contest of ideas, thought
The power of creativity www.originbranding.com. Pharmaceutical Branding 2012
The power of creativity www.originbranding.com Pharmaceutical Branding 2012 We are an independent, boutique agency passionately focused on developing pharmaceutical brands. For over 15 years we have delivered
Pharma working capital leaves room for improvement
October 2012 Pharma working capital leaves room for improvement 50.7 Billion in Excess Working Capital Ten years ago it was not unusual to be asked why working capital mattered to a pharmaceutical company.
Rx-360 An International Pharmaceutical Supply Chain Consortium
Rx-360 An International Pharmaceutical Supply Chain Consortium Overview Rx-360 and the Audit Sharing Program September 2011 Rx-360 Members (Continuously updated list at www.rx-360.org) Manufacturers (24)
INCENTIVE COMPENSATION CONFERENCE
Announcing the 2nd Annual ZS Associates INCENTIVE COMPENSATION CONFERENCE 08 September 23 24, 2008 Philadelphia, PA Incentive compensation greatly affects sales force motivation and morale. When designed
Multiple Sclerosis. Current and Future Players. GDHC1009FPR/ Published March 2013
Multiple Sclerosis Current and Future Players GDHC1009FPR/ Published March 2013 Executive Summary Moderate Growth in the Multiple Sclerosis Market is Expected from 2012 2022 GlobalData estimates the 2012
Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019
Brochure More information from http://www.researchandmarkets.com/reports/3453273/ Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Description: About non-small cell lung cancer therapeutics
6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality
6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality March 24-25, 2015 Wyndham Philadelphia Historic District, Philadelphia, PA www.exlevents.com/gcp Sponsors
Global Pharmaceuticals Marketing Channel Reference EDITION
Global Pharmaceuticals Marketing Channel Reference EDITION 2015 ABOUT IMS HEALTH IMS Health is a leading global information and technology services company providing clients in the healthcare industry
Stakeholder Insight: Rheumatoid arthritis - Rising competition by line and severity
Brochure More information from http://www.researchandmarkets.com/reports/1383065/ Stakeholder Insight: Rheumatoid arthritis - Rising competition by line and severity Description: Introduction Disease-modifying
Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies
Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies The Pharma Industry s Reputation in the Eyes of the General Public A Reputation Study with Consumers in 15 Countries RepTrak is a
Key Findings. Use this report to... The Autoimmune Market Outlook to 2013
Key Findings The global autoimmune market generated sales of $31.9bn in, an increase of 14.4% over 2006 sales. The market is forecast to grow at a CAGR of 8.1% to reach a total value of $51.0bn in 2013.
Global Peptide Therapeutics Market 2014-2018
Brochure More information from http://www.researchandmarkets.com/reports/3022209/ Global Peptide Therapeutics Market 2014-2018 Description: About Peptide Therapeutics Peptides are amino acids sequences
